about
Purification and mechanism of human aldehyde oxidase expressed in Escherichia coliOptimization of the Expression of Human Aldehyde Oxidase for Investigations of Single-Nucleotide PolymorphismsThe impact of single nucleotide polymorphisms on human aldehyde oxidaseIdentification of crucial amino acids in mouse aldehyde oxidase 3 that determine substrate specificityMechanism of porcine liver xanthine oxidoreductase mediated N-oxide reduction of cyadox as revealed by docking and mutagenesis studiesExpression Profile of Genes Related to Drug Metabolism in Human Brain TumorsAldehyde oxidase importance in vivo in xenobiotic metabolism: imidacloprid nitroreduction in mice.Evidence for substrate-dependent inhibition profiles for human liver aldehyde oxidase.Characterization of superoxide production from aldehyde oxidase: an important source of oxidants in biological tissues.The fourth mammalian molybdenum enzyme mARC: current state of research.Small-interference RNA-mediated knock-down of aldehyde oxidase 1 in 3T3-L1 cells impairs adipogenesis and adiponectin release.Monitoring in vivo metabolism and elimination of the endogenous DNA adduct, M1dG {3-(2-deoxy-beta-D-erythro-pentofuranosyl)pyrimido[1,2-alpha]purin-10(3H)-one}, by accelerator mass spectrometryA novel reaction mediated by human aldehyde oxidase: amide hydrolysis of GDC-0834The c-Met Tyrosine Kinase Inhibitor JNJ-38877605 Causes Renal Toxicity through Species-Specific Insoluble Metabolite FormationMolybdenum-containing nicotine hydroxylase genes in a nicotine degradation pathway that is a variant of the pyridine and pyrrolidine pathways.Effect of Cytochrome P450 Reductase Deficiency on 2-Amino-9H-pyrido[2,3-b]indole Metabolism and DNA Adduct Formation in Liver and Extrahepatic Tissues of Mice.Involvement of enzymes other than CYPs in the oxidative metabolism of xenobiotics.Predicting intrinsic clearance for drugs and drug candidates metabolized by aldehyde oxidase.Biomedical Technologies for in vitro Screening and Controlled Delivery of Neuroactive Compounds.Evaluation of rhesus monkey and guinea pig hepatic cytosol fractions as models for human aldehyde oxidase.Aldehyde oxidase functions as a superoxide generating NADH oxidase: an important redox regulated pathway of cellular oxygen radical formation.Inhibitory effects of flavonoids on molybdenum hydroxylases activity.Xanthine Oxidoreductase in Drug Metabolism: Beyond a Role as a Detoxifying Enzyme.Pharmacogenomics in the treatment of inflammatory bowel disease.Probe ADME and test hypotheses: a PATH beyond clearance in vitro-in vivo correlations in early drug discovery.Strategies for a comprehensive understanding of metabolism by aldehyde oxidase.Current status of prediction of drug disposition and toxicity in humans using chimeric mice with humanized liver.Electronic structure contributions to reactivity in xanthine oxidase family enzymes.A simple litmus test for aldehyde oxidase metabolism of heteroarenes.Challenges and Opportunities with Non-CYP Enzymes Aldehyde Oxidase, Carboxylesterase, and UDP-Glucuronosyltransferase: Focus on Reaction Phenotyping and Prediction of Human Clearance.Accumulation of amino-polyvinyl alcohol-coated superparamagnetic iron oxide nanoparticles in bone marrow: implications for local stromal cells.Effect of a controlled food-chain mediated exposure to cadmium and arsenic on oxidative enzymes in the tissues of rats.Oxidation and glycolytic cleavage of etheno and propano DNA base adducts.Conversion of the Pseudomonas aeruginosa Quinolone Signal and Related Alkylhydroxyquinolines by Rhodococcus sp. Strain BG43.Transport and metabolism of the antitumour drug candidate 2'-benzoyloxycinnamaldehyde in Caco-2 cells.Plasma pharmacokinetics and metabolism of the antitumour drug candidate 2'-benzoyloxycinnamaldehyde in rats.In silico and in vitro pharmacogenetics: aldehyde oxidase rapidly metabolizes a p38 kinase inhibitor.Aldehyde oxidase-dependent species difference in hepatic metabolism of fasudil to hydroxyfasudil.Going Beyond Common Drug Metabolizing Enzymes: Case Studies of Biotransformation Involving Aldehyde Oxidase, γ-Glutamyl Transpeptidase, Cathepsin B, Flavin-Containing Monooxygenase, and ADP-Ribosyltransferase.Species differences in metabolism of ripasudil (K-115) are attributed to aldehyde oxidase.
P2860
Q24649235-04134288-6B10-4EDC-8474-E9D3BDA801D7Q27703955-4AD69C7B-6E6D-43AE-B261-99D5DBBB73FBQ28258167-A0E8220B-D440-4785-BF7E-4DD909CCFDB2Q28507975-7AE1F33D-1A5F-45BB-92DF-C247D3FEC5FBQ28536938-EEE41620-FEFD-4E12-BE44-8141B72302B4Q28551028-DE7C0FBF-C7EE-44EE-AC6B-A29D3E067B16Q31813064-663D3BE2-9E36-4723-9F9C-2A18A9DA5E8DQ31814815-2B58FD72-6B17-4B5F-A12C-55A53935D0FEQ33815515-3AA6E580-319E-4BF9-A771-5281E4DE7523Q34028677-4956FC1F-025D-4C05-AE20-7B88232445AEQ34656848-1A869049-9ECF-4139-80F6-A259BCD9172AQ35545606-B99ED75F-70F6-49EA-A25C-A6FF87F8D078Q35600249-DC73ED97-9B94-4037-907C-6CE233C9B7A0Q35612898-03D91C3C-A6F4-42C3-8533-DB8618B5367AQ36279474-71585EDE-D12E-43FA-BF52-E36010A2274DQ36435702-96CC344A-CABC-4189-BA9E-6F1D0C480808Q36662870-9E7210B4-CCC6-4203-8EFC-860549155533Q36736202-FAB1BBDE-9F51-42AD-B552-C9B86E7C3283Q37010459-576666B5-EAAF-4460-84B2-1A2F493CF265Q37193120-3B5D83E4-23B2-4D2B-936B-CAD554D3FB96Q37638173-7C0444B1-6FE0-4E86-BBD5-CB6806C72DC6Q37679897-94115E33-8859-405A-92C1-7E12955EF2D1Q37692717-6875E82E-E724-4996-B4CD-ED7ED5869838Q37710516-0170E296-BCF5-4458-8E05-4107E1FCE271Q38017309-16E67D51-FB72-4DD2-8490-BF191143E6C4Q38066611-52FC6049-46DD-4D91-ABD8-BFF2019EDF4CQ38170468-BB92CB97-D64B-4B8D-BF17-6CF3361E58CDQ38271480-FC3E5F10-7169-48BE-8AF4-1F5D7AF5B3F5Q38705494-761A3A0B-EC6D-4FBB-A0BA-9787D31DE267Q38799423-271F4CC8-D541-44DD-B2D8-626651941167Q38980814-9A91A9BD-5E3A-4631-A3CD-F776D6FF3C91Q41679380-6858DAF7-4D06-4112-AF8C-7B55D88459BAQ41877393-D905A542-28C2-415A-9FDA-D274D6E3BCAEQ41882011-747EB08E-251C-45B6-A7AB-AF193CF37D7BQ43238709-0557CFDD-6673-44EC-91CE-36A9A288B4B0Q46091284-2ADEA8CF-7042-490B-8D5A-ED76B7958BFDQ46399560-531C60B0-0F9F-425F-8F99-DF703F7DE226Q46422523-A631F412-1A3A-433B-A47B-B6A15FDFE786Q46554332-D84AD3AA-3DB8-4563-9AD3-C2D57B1D9C43Q46622705-A0B52849-F3C7-4ED2-B22C-367C019CFA57
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Drug-metabolizing ability of molybdenum hydroxylases.
@ast
Drug-metabolizing ability of molybdenum hydroxylases.
@en
type
label
Drug-metabolizing ability of molybdenum hydroxylases.
@ast
Drug-metabolizing ability of molybdenum hydroxylases.
@en
prefLabel
Drug-metabolizing ability of molybdenum hydroxylases.
@ast
Drug-metabolizing ability of molybdenum hydroxylases.
@en
P2093
P356
P1476
Drug-metabolizing ability of molybdenum hydroxylases.
@en
P2093
Kazumi Sugihara
Shigeru Ohta
Shigeyuki Kitamura
P356
10.2133/DMPK.21.83
P577
2006-04-01T00:00:00Z